id	sid	tid	token	lemma	pos
ajlm-1298	1	1	acknowledgements	acknowledgement	NOUN
ajlm-1298	1	2	references	reference	NOUN
ajlm-1298	1	3	about	about	ADP
ajlm-1298	1	4	the	the	DET
ajlm-1298	1	5	author(s	author(s	NOUN
ajlm-1298	1	6	)	)	PUNCT
ajlm-1298	1	7	awadia	awadia	PROPN
ajlm-1298	1	8	a.	a.	PROPN
ajlm-1298	1	9	ahmeidi	ahmeidi	PROPN
ajlm-1298	1	10	department	department	PROPN
ajlm-1298	1	11	hematology	hematology	PROPN
ajlm-1298	1	12	,	,	PUNCT
ajlm-1298	1	13	faculty	faculty	NOUN
ajlm-1298	1	14	of	of	ADP
ajlm-1298	1	15	medical	medical	ADJ
ajlm-1298	1	16	laboratory	laboratory	NOUN
ajlm-1298	1	17	science	science	NOUN
ajlm-1298	1	18	,	,	PUNCT
ajlm-1298	1	19	university	university	NOUN
ajlm-1298	1	20	of	of	ADP
ajlm-1298	1	21	science	science	NOUN
ajlm-1298	1	22	and	and	CCONJ
ajlm-1298	1	23	technology	technology	NOUN
ajlm-1298	1	24	,	,	PUNCT
ajlm-1298	1	25	khartoum	khartoum	PROPN
ajlm-1298	1	26	,	,	PUNCT
ajlm-1298	1	27	sudan	sudan	PROPN
ajlm-1298	1	28	ashraf	ashraf	PROPN
ajlm-1298	1	29	musa	musa	PROPN
ajlm-1298	1	30	abeer	abeer	PROPN
ajlm-1298	1	31	hospital	hospital	PROPN
ajlm-1298	1	32	,	,	PUNCT
ajlm-1298	1	33	muscat	muscat	PROPN
ajlm-1298	1	34	,	,	PUNCT
ajlm-1298	1	35	oman	oman	PROPN
ajlm-1298	1	36	hend	hend	PROPN
ajlm-1298	1	37	s.	s.	PROPN
ajlm-1298	1	38	ahmed	ahmed	PROPN
ajlm-1298	1	39	department	department	PROPN
ajlm-1298	1	40	hematology	hematology	PROPN
ajlm-1298	1	41	and	and	CCONJ
ajlm-1298	1	42	blood	blood	NOUN
ajlm-1298	1	43	transfusion	transfusion	NOUN
ajlm-1298	1	44	,	,	PUNCT
ajlm-1298	1	45	faculty	faculty	NOUN
ajlm-1298	1	46	of	of	ADP
ajlm-1298	1	47	medical	medical	ADJ
ajlm-1298	1	48	laboratory	laboratory	NOUN
ajlm-1298	1	49	science	science	NOUN
ajlm-1298	1	50	,	,	PUNCT
ajlm-1298	1	51	omdurman	omdurman	PROPN
ajlm-1298	1	52	ahlia	ahlia	PROPN
ajlm-1298	1	53	university	university	PROPN
ajlm-1298	1	54	,	,	PUNCT
ajlm-1298	1	55	khartoum	khartoum	PROPN
ajlm-1298	1	56	,	,	PUNCT
ajlm-1298	1	57	sudan	sudan	PROPN
ajlm-1298	1	58	adel	adel	PROPN
ajlm-1298	1	59	a.	a.	PROPN
ajlm-1298	1	60	elahmar	elahmar	PROPN
ajlm-1298	1	61	communicable	communicable	NOUN
ajlm-1298	1	62	disease	disease	NOUN
ajlm-1298	1	63	center	center	NOUN
ajlm-1298	1	64	,	,	PUNCT
ajlm-1298	1	65	harmad	harmad	ADJ
ajlm-1298	1	66	medical	medical	ADJ
ajlm-1298	1	67	corporation	corporation	NOUN
ajlm-1298	1	68	,	,	PUNCT
ajlm-1298	1	69	doha	doha	PROPN
ajlm-1298	1	70	,	,	PUNCT
ajlm-1298	1	71	qatar	qatar	PROPN
ajlm-1298	1	72	ryhana	ryhana	PROPN
ajlm-1298	1	73	b.	b.	PROPN
ajlm-1298	2	1	goota	goota	PROPN
ajlm-1298	2	2	ministry	ministry	PROPN
ajlm-1298	2	3	of	of	ADP
ajlm-1298	2	4	health	health	PROPN
ajlm-1298	2	5	,	,	PUNCT
ajlm-1298	2	6	khartoum	khartoum	PROPN
ajlm-1298	2	7	,	,	PUNCT
ajlm-1298	2	8	sudan	sudan	PROPN
ajlm-1298	2	9	ibtihal	ibtihal	PROPN
ajlm-1298	2	10	a.	a.	PROPN
ajlm-1298	2	11	ahmed	ahmed	PROPN
ajlm-1298	2	12	faculty	faculty	PROPN
ajlm-1298	2	13	of	of	ADP
ajlm-1298	2	14	medical	medical	ADJ
ajlm-1298	2	15	laboratory	laboratory	NOUN
ajlm-1298	2	16	science	science	NOUN
ajlm-1298	2	17	,	,	PUNCT
ajlm-1298	2	18	ibn	ibn	PROPN
ajlm-1298	2	19	sina	sina	PROPN
ajlm-1298	2	20	university	university	PROPN
ajlm-1298	2	21	,	,	PUNCT
ajlm-1298	2	22	khartoum	khartoum	PROPN
ajlm-1298	2	23	,	,	PUNCT
ajlm-1298	2	24	sudan	sudan	PROPN
ajlm-1298	2	25	abdelhakam	abdelhakam	PROPN
ajlm-1298	2	26	h.	h.	PROPN
ajlm-1298	2	27	ali	ali	PROPN
ajlm-1298	2	28	department	department	PROPN
ajlm-1298	2	29	microbiology	microbiology	NOUN
ajlm-1298	2	30	,	,	PUNCT
ajlm-1298	2	31	faculty	faculty	NOUN
ajlm-1298	2	32	of	of	ADP
ajlm-1298	2	33	medical	medical	ADJ
ajlm-1298	2	34	laboratory	laboratory	NOUN
ajlm-1298	2	35	science	science	NOUN
ajlm-1298	2	36	,	,	PUNCT
ajlm-1298	2	37	university	university	NOUN
ajlm-1298	2	38	of	of	ADP
ajlm-1298	2	39	al	al	PROPN
ajlm-1298	2	40	butana	butana	PROPN
ajlm-1298	2	41	,	,	PUNCT
ajlm-1298	2	42	rufaa	rufaa	NOUN
ajlm-1298	2	43	,	,	PUNCT
ajlm-1298	2	44	sudan	sudan	PROPN
ajlm-1298	2	45	mushal	mushal	PROPN
ajlm-1298	2	46	allam	allam	PROPN
ajlm-1298	2	47	national	national	PROPN
ajlm-1298	2	48	institute	institute	PROPN
ajlm-1298	2	49	for	for	ADP
ajlm-1298	2	50	communicable	communicable	NOUN
ajlm-1298	2	51	diseases	disease	NOUN
ajlm-1298	2	52	,	,	PUNCT
ajlm-1298	2	53	national	national	PROPN
ajlm-1298	2	54	health	health	PROPN
ajlm-1298	2	55	laboratory	laboratory	PROPN
ajlm-1298	2	56	service	service	PROPN
ajlm-1298	2	57	,	,	PUNCT
ajlm-1298	2	58	johannesburg	johannesburg	PROPN
ajlm-1298	2	59	,	,	PUNCT
ajlm-1298	2	60	south	south	PROPN
ajlm-1298	2	61	africa	africa	PROPN
ajlm-1298	2	62	mozan	mozan	PROPN
ajlm-1298	2	63	o.	o.	PROPN
ajlm-1298	2	64	hassan	hassan	PROPN
ajlm-1298	2	65	department	department	PROPN
ajlm-1298	2	66	hematology	hematology	PROPN
ajlm-1298	2	67	and	and	CCONJ
ajlm-1298	2	68	blood	blood	NOUN
ajlm-1298	2	69	transfusion	transfusion	NOUN
ajlm-1298	2	70	,	,	PUNCT
ajlm-1298	2	71	faculty	faculty	NOUN
ajlm-1298	2	72	of	of	ADP
ajlm-1298	2	73	medical	medical	ADJ
ajlm-1298	2	74	laboratory	laboratory	NOUN
ajlm-1298	2	75	science	science	NOUN
ajlm-1298	2	76	,	,	PUNCT
ajlm-1298	2	77	omdurman	omdurman	PROPN
ajlm-1298	2	78	ahlia	ahlia	PROPN
ajlm-1298	2	79	university	university	PROPN
ajlm-1298	2	80	,	,	PUNCT
ajlm-1298	2	81	khartoum	khartoum	PROPN
ajlm-1298	2	82	,	,	PUNCT
ajlm-1298	2	83	sudan	sudan	PROPN
ajlm-1298	2	84	citation	citation	PROPN
ajlm-1298	2	85	ahmeidi	ahmeidi	PROPN
ajlm-1298	2	86	a.a	a.a	PROPN
ajlm-1298	2	87	,	,	PUNCT
ajlm-1298	2	88	musa	musa	PROPN
ajlm-1298	2	89	a	a	PROPN
ajlm-1298	2	90	,	,	PUNCT
ajlm-1298	2	91	ahmed	ahmed	PROPN
ajlm-1298	2	92	h.s	h.s	PROPN
ajlm-1298	2	93	,	,	PUNCT
ajlm-1298	2	94	et	et	PROPN
ajlm-1298	2	95	al	al	PROPN
ajlm-1298	2	96	.	.	PUNCT
ajlm-1298	3	1	inflammatory	inflammatory	ADJ
ajlm-1298	3	2	markers	marker	NOUN
ajlm-1298	3	3	as	as	ADP
ajlm-1298	3	4	predictors	predictor	NOUN
ajlm-1298	3	5	of	of	ADP
ajlm-1298	3	6	mortality	mortality	NOUN
ajlm-1298	3	7	in	in	ADP
ajlm-1298	3	8	covid-19	covid-19	PROPN
ajlm-1298	3	9	infection	infection	NOUN
ajlm-1298	3	10	.	.	PUNCT
ajlm-1298	4	1	afr	afr	PROPN
ajlm-1298	4	2	j	j	PROPN
ajlm-1298	4	3	lab	lab	PROPN
ajlm-1298	4	4	med	me	VERB
ajlm-1298	4	5	.	.	PUNCT
ajlm-1298	4	6	2020;9(1	2020;9(1	NUM
ajlm-1298	4	7	)	)	PUNCT
ajlm-1298	4	8	,	,	PUNCT
ajlm-1298	4	9	a1298	a1298	PROPN
ajlm-1298	4	10	.	.	PUNCT
ajlm-1298	5	1	https://doi.org/10.4102/ajlm.v9i1.1298	https://doi.org/10.4102/ajlm.v9i1.1298	PROPN
ajlm-1298	5	2	scientific	scientific	ADJ
ajlm-1298	5	3	letter	letter	NOUN
ajlm-1298	5	4	inflammatory	inflammatory	ADJ
ajlm-1298	5	5	markers	marker	NOUN
ajlm-1298	5	6	as	as	ADP
ajlm-1298	5	7	predictors	predictor	NOUN
ajlm-1298	5	8	of	of	ADP
ajlm-1298	5	9	mortality	mortality	NOUN
ajlm-1298	5	10	in	in	ADP
ajlm-1298	5	11	covid-19	covid-19	PROPN
ajlm-1298	5	12	infection	infection	NOUN
ajlm-1298	5	13	awadia	awadia	PROPN
ajlm-1298	5	14	a.	a.	NOUN
ajlm-1298	5	15	ahmeidi	ahmeidi	PROPN
ajlm-1298	5	16	,	,	PUNCT
ajlm-1298	5	17	ashraf	ashraf	PROPN
ajlm-1298	5	18	musa	musa	PROPN
ajlm-1298	5	19	,	,	PUNCT
ajlm-1298	5	20	hend	hend	PROPN
ajlm-1298	5	21	s.	s.	PROPN
ajlm-1298	5	22	ahmed	ahmed	PROPN
ajlm-1298	5	23	,	,	PUNCT
ajlm-1298	5	24	adel	adel	PROPN
ajlm-1298	5	25	a.	a.	PROPN
ajlm-1298	5	26	elahmar	elahmar	PROPN
ajlm-1298	5	27	,	,	PUNCT
ajlm-1298	5	28	ryhana	ryhana	PROPN
ajlm-1298	5	29	b.	b.	PROPN
ajlm-1298	5	30	goota	goota	PROPN
ajlm-1298	5	31	,	,	PUNCT
ajlm-1298	5	32	ibtihal	ibtihal	NOUN
ajlm-1298	5	33	a.	a.	NOUN
ajlm-1298	5	34	ahmed	ahmed	PROPN
ajlm-1298	5	35	,	,	PUNCT
ajlm-1298	5	36	abdelhakam	abdelhakam	PROPN
ajlm-1298	5	37	h.	h.	PROPN
ajlm-1298	5	38	ali	ali	PROPN
ajlm-1298	5	39	,	,	PUNCT
ajlm-1298	5	40	mushal	mushal	PROPN
ajlm-1298	5	41	allam	allam	PROPN
ajlm-1298	5	42	,	,	PUNCT
ajlm-1298	5	43	mozan	mozan	PROPN
ajlm-1298	5	44	o.	o.	PROPN
ajlm-1298	5	45	hassan	hassan	PROPN
ajlm-1298	5	46	received	receive	VERB
ajlm-1298	5	47	:	:	PUNCT
ajlm-1298	5	48	12	12	NUM
ajlm-1298	5	49	june	june	PROPN
ajlm-1298	5	50	2020	2020	NUM
ajlm-1298	5	51	;	;	PUNCT
ajlm-1298	5	52	accepted	accept	VERB
ajlm-1298	5	53	:	:	PUNCT
ajlm-1298	5	54	07	07	NUM
ajlm-1298	5	55	oct	oct	PROPN
ajlm-1298	5	56	.	.	PROPN
ajlm-1298	5	57	2020	2020	NUM
ajlm-1298	5	58	;	;	PUNCT
ajlm-1298	5	59	published	publish	VERB
ajlm-1298	5	60	:	:	PUNCT
ajlm-1298	5	61	21	21	NUM
ajlm-1298	5	62	dec	dec	PROPN
ajlm-1298	5	63	.	.	PROPN
ajlm-1298	5	64	2020	2020	NUM
ajlm-1298	6	1	copyright	copyright	NOUN
ajlm-1298	6	2	:	:	PUNCT
ajlm-1298	6	3	©	©	PROPN
ajlm-1298	6	4	2020	2020	NUM
ajlm-1298	6	5	.	.	PUNCT
ajlm-1298	7	1	the	the	DET
ajlm-1298	7	2	author(s	author(s	PROPN
ajlm-1298	7	3	)	)	PUNCT
ajlm-1298	7	4	.	.	PUNCT
ajlm-1298	8	1	licensee	licensee	NOUN
ajlm-1298	8	2	:	:	PUNCT
ajlm-1298	8	3	aosis	aosis	NOUN
ajlm-1298	8	4	.	.	PUNCT
ajlm-1298	9	1	this	this	PRON
ajlm-1298	9	2	is	be	AUX
ajlm-1298	9	3	an	an	DET
ajlm-1298	9	4	open	open	ADJ
ajlm-1298	9	5	access	access	NOUN
ajlm-1298	9	6	article	article	NOUN
ajlm-1298	9	7	distributed	distribute	VERB
ajlm-1298	9	8	under	under	ADP
ajlm-1298	9	9	the	the	DET
ajlm-1298	9	10	terms	term	NOUN
ajlm-1298	9	11	of	of	ADP
ajlm-1298	9	12	the	the	DET
ajlm-1298	9	13	creative	creative	ADJ
ajlm-1298	9	14	commons	common	NOUN
ajlm-1298	9	15	attribution	attribution	NOUN
ajlm-1298	9	16	license	license	NOUN
ajlm-1298	9	17	,	,	PUNCT
ajlm-1298	9	18	which	which	PRON
ajlm-1298	9	19	permits	permit	VERB
ajlm-1298	9	20	unrestricted	unrestricted	ADJ
ajlm-1298	9	21	use	use	NOUN
ajlm-1298	9	22	,	,	PUNCT
ajlm-1298	9	23	distribution	distribution	NOUN
ajlm-1298	9	24	,	,	PUNCT
ajlm-1298	9	25	and	and	CCONJ
ajlm-1298	9	26	reproduction	reproduction	NOUN
ajlm-1298	9	27	in	in	ADP
ajlm-1298	9	28	any	any	DET
ajlm-1298	9	29	medium	medium	NOUN
ajlm-1298	9	30	,	,	PUNCT
ajlm-1298	9	31	provided	provide	VERB
ajlm-1298	9	32	the	the	DET
ajlm-1298	9	33	original	original	ADJ
ajlm-1298	9	34	work	work	NOUN
ajlm-1298	9	35	is	be	AUX
ajlm-1298	9	36	properly	properly	ADV
ajlm-1298	9	37	cited	cite	VERB
ajlm-1298	9	38	.	.	PUNCT
ajlm-1298	10	1	since	since	SCONJ
ajlm-1298	10	2	the	the	DET
ajlm-1298	10	3	origination	origination	NOUN
ajlm-1298	10	4	of	of	ADP
ajlm-1298	10	5	the	the	DET
ajlm-1298	10	6	severe	severe	ADJ
ajlm-1298	10	7	acute	acute	ADJ
ajlm-1298	10	8	respiratory	respiratory	ADJ
ajlm-1298	10	9	syndrome	syndrome	NOUN
ajlm-1298	10	10	coronavirus-2	coronavirus-2	NUM
ajlm-1298	10	11	(	(	PUNCT
ajlm-1298	10	12	sars	sar	NOUN
ajlm-1298	10	13	-	-	PUNCT
ajlm-1298	10	14	cov-2	cov-2	NOUN
ajlm-1298	10	15	)	)	PUNCT
ajlm-1298	10	16	in	in	ADP
ajlm-1298	10	17	china	china	PROPN
ajlm-1298	10	18	in	in	ADP
ajlm-1298	10	19	december	december	PROPN
ajlm-1298	10	20	2019	2019	NUM
ajlm-1298	10	21	and	and	CCONJ
ajlm-1298	10	22	its	its	PRON
ajlm-1298	10	23	subsequent	subsequent	ADJ
ajlm-1298	10	24	global	global	ADJ
ajlm-1298	10	25	spread	spread	NOUN
ajlm-1298	10	26	,	,	PUNCT
ajlm-1298	10	27	it	it	PRON
ajlm-1298	10	28	became	become	VERB
ajlm-1298	10	29	critical	critical	ADJ
ajlm-1298	10	30	to	to	PART
ajlm-1298	10	31	understand	understand	VERB
ajlm-1298	10	32	the	the	DET
ajlm-1298	10	33	inflammatory	inflammatory	ADJ
ajlm-1298	10	34	process	process	NOUN
ajlm-1298	10	35	associated	associate	VERB
ajlm-1298	10	36	with	with	ADP
ajlm-1298	10	37	this	this	DET
ajlm-1298	10	38	virus	virus	NOUN
ajlm-1298	10	39	and	and	CCONJ
ajlm-1298	10	40	the	the	DET
ajlm-1298	10	41	coronavirus	coronavirus	NOUN
ajlm-1298	10	42	disease	disease	NOUN
ajlm-1298	10	43	2019	2019	NUM
ajlm-1298	10	44	(	(	PUNCT
ajlm-1298	10	45	covid-19	covid-19	PROPN
ajlm-1298	10	46	)	)	PUNCT
ajlm-1298	10	47	and	and	CCONJ
ajlm-1298	10	48	to	to	PART
ajlm-1298	10	49	understand	understand	VERB
ajlm-1298	10	50	the	the	DET
ajlm-1298	10	51	changes	change	NOUN
ajlm-1298	10	52	associated	associate	VERB
ajlm-1298	10	53	with	with	ADP
ajlm-1298	10	54	the	the	DET
ajlm-1298	10	55	different	different	ADJ
ajlm-1298	10	56	inflammatory	inflammatory	ADJ
ajlm-1298	10	57	parameters	parameter	NOUN
ajlm-1298	10	58	.	.	PUNCT
ajlm-1298	11	1	the	the	DET
ajlm-1298	11	2	clinical	clinical	ADJ
ajlm-1298	11	3	presentation	presentation	NOUN
ajlm-1298	11	4	of	of	ADP
ajlm-1298	11	5	covid-19	covid-19	PROPN
ajlm-1298	11	6	cases	case	NOUN
ajlm-1298	11	7	varies	vary	VERB
ajlm-1298	11	8	greatly	greatly	ADV
ajlm-1298	11	9	from	from	ADP
ajlm-1298	11	10	mild	mild	ADJ
ajlm-1298	11	11	symptoms	symptom	NOUN
ajlm-1298	11	12	among	among	ADP
ajlm-1298	11	13	the	the	DET
ajlm-1298	11	14	majority	majority	NOUN
ajlm-1298	11	15	of	of	ADP
ajlm-1298	11	16	patients	patient	NOUN
ajlm-1298	11	17	,	,	PUNCT
ajlm-1298	11	18	to	to	ADP
ajlm-1298	11	19	severe	severe	ADJ
ajlm-1298	11	20	disease	disease	NOUN
ajlm-1298	11	21	leading	lead	VERB
ajlm-1298	11	22	to	to	ADP
ajlm-1298	11	23	death	death	NOUN
ajlm-1298	11	24	in	in	ADP
ajlm-1298	11	25	some	some	DET
ajlm-1298	11	26	patients	patient	NOUN
ajlm-1298	11	27	.	.	PUNCT
ajlm-1298	12	1	many	many	ADJ
ajlm-1298	12	2	covid-19	covid-19	PROPN
ajlm-1298	12	3	cases	case	NOUN
ajlm-1298	12	4	had	have	VERB
ajlm-1298	12	5	increased	increase	VERB
ajlm-1298	12	6	levels	level	NOUN
ajlm-1298	12	7	of	of	ADP
ajlm-1298	12	8	inflammatory	inflammatory	ADJ
ajlm-1298	12	9	cytokines	cytokine	NOUN
ajlm-1298	12	10	and	and	CCONJ
ajlm-1298	12	11	other	other	ADJ
ajlm-1298	12	12	infection	infection	NOUN
ajlm-1298	12	13	-	-	PUNCT
ajlm-1298	12	14	related	relate	VERB
ajlm-1298	12	15	biomarkers.1	biomarkers.1	NOUN
ajlm-1298	12	16	the	the	DET
ajlm-1298	12	17	inflammatory	inflammatory	ADJ
ajlm-1298	12	18	markers	marker	NOUN
ajlm-1298	12	19	,	,	PUNCT
ajlm-1298	12	20	including	include	VERB
ajlm-1298	12	21	interleukin-6	interleukin-6	NUM
ajlm-1298	12	22	,	,	PUNCT
ajlm-1298	12	23	d	d	NOUN
ajlm-1298	12	24	-	-	PUNCT
ajlm-1298	12	25	dimer	dimer	ADJ
ajlm-1298	12	26	,	,	PUNCT
ajlm-1298	12	27	neutrophil	neutrophil	ADJ
ajlm-1298	12	28	-	-	PUNCT
ajlm-1298	12	29	to	to	ADP
ajlm-1298	12	30	-	-	PUNCT
ajlm-1298	12	31	lymphocyte	lymphocyte	ADJ
ajlm-1298	12	32	ratio	ratio	NOUN
ajlm-1298	12	33	and	and	CCONJ
ajlm-1298	12	34	high	high	ADJ
ajlm-1298	12	35	-	-	PUNCT
ajlm-1298	12	36	sensitivity	sensitivity	NOUN
ajlm-1298	12	37	c	c	NOUN
ajlm-1298	12	38	-	-	PUNCT
ajlm-1298	12	39	reactive	reactive	ADJ
ajlm-1298	12	40	protein	protein	NOUN
ajlm-1298	12	41	(	(	PUNCT
ajlm-1298	12	42	hs	hs	NOUN
ajlm-1298	12	43	-	-	PUNCT
ajlm-1298	12	44	crp	crp	NOUN
ajlm-1298	12	45	)	)	PUNCT
ajlm-1298	12	46	levels	level	NOUN
ajlm-1298	12	47	,	,	PUNCT
ajlm-1298	12	48	were	be	AUX
ajlm-1298	12	49	found	find	VERB
ajlm-1298	12	50	to	to	PART
ajlm-1298	12	51	be	be	AUX
ajlm-1298	12	52	indicative	indicative	ADJ
ajlm-1298	12	53	of	of	ADP
ajlm-1298	12	54	severe	severe	ADJ
ajlm-1298	12	55	covid-19	covid-19	PROPN
ajlm-1298	12	56	in	in	ADP
ajlm-1298	12	57	reports	report	NOUN
ajlm-1298	12	58	that	that	PRON
ajlm-1298	12	59	emerged	emerge	VERB
ajlm-1298	12	60	from	from	ADP
ajlm-1298	12	61	china.2	china.2	PROPN
ajlm-1298	12	62	however	however	ADV
ajlm-1298	12	63	,	,	PUNCT
ajlm-1298	12	64	their	their	PRON
ajlm-1298	12	65	association	association	NOUN
ajlm-1298	12	66	with	with	ADP
ajlm-1298	12	67	mortality	mortality	NOUN
ajlm-1298	12	68	among	among	ADP
ajlm-1298	12	69	covid-19	covid-19	PROPN
ajlm-1298	12	70	patients	patient	NOUN
ajlm-1298	12	71	has	have	AUX
ajlm-1298	12	72	not	not	PART
ajlm-1298	12	73	been	be	AUX
ajlm-1298	12	74	reviewed	review	VERB
ajlm-1298	12	75	.	.	PUNCT
ajlm-1298	13	1	in	in	ADP
ajlm-1298	13	2	this	this	DET
ajlm-1298	13	3	article	article	NOUN
ajlm-1298	13	4	,	,	PUNCT
ajlm-1298	13	5	we	we	PRON
ajlm-1298	13	6	identify	identify	VERB
ajlm-1298	13	7	inflammatory	inflammatory	ADJ
ajlm-1298	13	8	markers	marker	NOUN
ajlm-1298	13	9	(	(	PUNCT
ajlm-1298	13	10	interleukin-6	interleukin-6	PROPN
ajlm-1298	13	11	,	,	PUNCT
ajlm-1298	13	12	d	d	NOUN
ajlm-1298	13	13	-	-	PUNCT
ajlm-1298	13	14	dimer	dimer	ADJ
ajlm-1298	13	15	,	,	PUNCT
ajlm-1298	13	16	neutrophil	neutrophil	ADJ
ajlm-1298	13	17	-	-	PUNCT
ajlm-1298	13	18	to	to	ADP
ajlm-1298	13	19	-	-	PUNCT
ajlm-1298	13	20	lymphocyte	lymphocyte	NOUN
ajlm-1298	13	21	ratio	ratio	NOUN
ajlm-1298	13	22	and	and	CCONJ
ajlm-1298	13	23	hs	hs	PROPN
ajlm-1298	13	24	-	-	PROPN
ajlm-1298	13	25	crp	crp	NOUN
ajlm-1298	13	26	)	)	PUNCT
ajlm-1298	13	27	as	as	ADP
ajlm-1298	13	28	predictors	predictor	NOUN
ajlm-1298	13	29	of	of	ADP
ajlm-1298	13	30	covid-19	covid-19	PROPN
ajlm-1298	13	31	mortality	mortality	NOUN
ajlm-1298	13	32	.	.	PUNCT
ajlm-1298	14	1	laboratory	laboratory	NOUN
ajlm-1298	14	2	tests	test	NOUN
ajlm-1298	14	3	for	for	ADP
ajlm-1298	14	4	these	these	DET
ajlm-1298	14	5	markers	marker	NOUN
ajlm-1298	14	6	are	be	AUX
ajlm-1298	14	7	simple	simple	ADJ
ajlm-1298	14	8	,	,	PUNCT
ajlm-1298	14	9	cheap	cheap	ADJ
ajlm-1298	14	10	and	and	CCONJ
ajlm-1298	14	11	available	available	ADJ
ajlm-1298	14	12	and	and	CCONJ
ajlm-1298	14	13	can	can	AUX
ajlm-1298	14	14	be	be	AUX
ajlm-1298	14	15	performed	perform	VERB
ajlm-1298	14	16	in	in	ADP
ajlm-1298	14	17	outbreak	outbreak	NOUN
ajlm-1298	14	18	areas	area	NOUN
ajlm-1298	14	19	with	with	ADP
ajlm-1298	14	20	limited	limited	ADJ
ajlm-1298	14	21	resources	resource	NOUN
ajlm-1298	14	22	.	.	PUNCT
ajlm-1298	15	1	according	accord	VERB
ajlm-1298	15	2	to	to	ADP
ajlm-1298	15	3	zhou	zhou	PROPN
ajlm-1298	15	4	et	et	PROPN
ajlm-1298	15	5	al	al	PROPN
ajlm-1298	15	6	.	.	PROPN
ajlm-1298	15	7	,	,	PUNCT
ajlm-1298	15	8	d	d	X
ajlm-1298	15	9	-	-	PUNCT
ajlm-1298	15	10	dimer	dimer	ADJ
ajlm-1298	15	11	levels	level	NOUN
ajlm-1298	15	12	exceeding	exceed	VERB
ajlm-1298	15	13	1.0	1.0	NUM
ajlm-1298	15	14	µg	µg	NOUN
ajlm-1298	15	15	/	/	SYM
ajlm-1298	15	16	ml	ml	NOUN
ajlm-1298	15	17	at	at	ADP
ajlm-1298	15	18	hospital	hospital	NOUN
ajlm-1298	15	19	admission	admission	NOUN
ajlm-1298	15	20	correlated	correlate	VERB
ajlm-1298	15	21	significantly	significantly	ADV
ajlm-1298	15	22	with	with	ADP
ajlm-1298	15	23	death	death	NOUN
ajlm-1298	15	24	among	among	ADP
ajlm-1298	15	25	hospitalised	hospitalise	VERB
ajlm-1298	15	26	covid-19	covid-19	PROPN
ajlm-1298	15	27	patients	patient	NOUN
ajlm-1298	15	28	in	in	ADP
ajlm-1298	15	29	china	china	PROPN
ajlm-1298	15	30	,	,	PUNCT
ajlm-1298	15	31	with	with	ADP
ajlm-1298	15	32	a	a	DET
ajlm-1298	15	33	p	p	NOUN
ajlm-1298	15	34	-	-	PUNCT
ajlm-1298	15	35	value	value	NOUN
ajlm-1298	15	36	of	of	ADP
ajlm-1298	15	37	less	less	ADJ
ajlm-1298	15	38	than	than	ADP
ajlm-1298	15	39	0.001.3	0.001.3	NUM
ajlm-1298	15	40	another	another	DET
ajlm-1298	15	41	study	study	NOUN
ajlm-1298	15	42	in	in	ADP
ajlm-1298	15	43	wuhan	wuhan	PROPN
ajlm-1298	15	44	,	,	PUNCT
ajlm-1298	15	45	china	china	PROPN
ajlm-1298	15	46	,	,	PUNCT
ajlm-1298	15	47	which	which	PRON
ajlm-1298	15	48	included	include	VERB
ajlm-1298	15	49	343	343	NUM
ajlm-1298	15	50	in	in	ADP
ajlm-1298	15	51	-	-	PUNCT
ajlm-1298	15	52	patients	patient	NOUN
ajlm-1298	15	53	with	with	ADP
ajlm-1298	15	54	confirmed	confirm	VERB
ajlm-1298	15	55	covid-19	covid-19	PROPN
ajlm-1298	15	56	,	,	PUNCT
ajlm-1298	15	57	showed	show	VERB
ajlm-1298	15	58	that	that	SCONJ
ajlm-1298	15	59	elevated	elevated	ADJ
ajlm-1298	15	60	d	d	ADJ
ajlm-1298	15	61	-	-	PUNCT
ajlm-1298	15	62	dimer	dimer	ADJ
ajlm-1298	15	63	levels	level	NOUN
ajlm-1298	15	64	over	over	ADP
ajlm-1298	15	65	2	2	NUM
ajlm-1298	15	66	µg	µg	NOUN
ajlm-1298	15	67	/	/	SYM
ajlm-1298	15	68	ml	ml	NOUN
ajlm-1298	15	69	at	at	ADP
ajlm-1298	15	70	an	an	DET
ajlm-1298	15	71	early	early	ADJ
ajlm-1298	15	72	stage	stage	NOUN
ajlm-1298	15	73	of	of	ADP
ajlm-1298	15	74	hospitalisation	hospitalisation	NOUN
ajlm-1298	15	75	correlated	correlate	VERB
ajlm-1298	15	76	significantly	significantly	ADV
ajlm-1298	15	77	with	with	ADP
ajlm-1298	15	78	a	a	DET
ajlm-1298	15	79	high	high	ADJ
ajlm-1298	15	80	risk	risk	NOUN
ajlm-1298	15	81	of	of	ADP
ajlm-1298	15	82	death.4	death.4	NOUN
ajlm-1298	15	83	also	also	ADV
ajlm-1298	15	84	,	,	PUNCT
ajlm-1298	15	85	according	accord	VERB
ajlm-1298	15	86	to	to	ADP
ajlm-1298	15	87	another	another	DET
ajlm-1298	15	88	study	study	NOUN
ajlm-1298	15	89	from	from	ADP
ajlm-1298	15	90	china	china	PROPN
ajlm-1298	15	91	that	that	PRON
ajlm-1298	15	92	included	include	VERB
ajlm-1298	15	93	1099	1099	NUM
ajlm-1298	15	94	confirmed	confirm	VERB
ajlm-1298	15	95	covid-19	covid-19	PROPN
ajlm-1298	15	96	patients	patient	NOUN
ajlm-1298	15	97	,	,	PUNCT
ajlm-1298	15	98	results	result	NOUN
ajlm-1298	15	99	revealed	reveal	VERB
ajlm-1298	15	100	that	that	SCONJ
ajlm-1298	15	101	median	median	ADJ
ajlm-1298	15	102	d	d	NOUN
ajlm-1298	15	103	-	-	PUNCT
ajlm-1298	15	104	dimer	dimer	NOUN
ajlm-1298	15	105	and	and	CCONJ
ajlm-1298	15	106	c	c	NOUN
ajlm-1298	15	107	-	-	PUNCT
ajlm-1298	15	108	reactive	reactive	ADJ
ajlm-1298	15	109	protein	protein	NOUN
ajlm-1298	15	110	levels	level	NOUN
ajlm-1298	15	111	were	be	AUX
ajlm-1298	15	112	higher	high	ADJ
ajlm-1298	15	113	among	among	ADP
ajlm-1298	15	114	severe	severe	ADJ
ajlm-1298	15	115	cases	case	NOUN
ajlm-1298	15	116	compared	compare	VERB
ajlm-1298	15	117	to	to	ADP
ajlm-1298	15	118	non	non	ADJ
ajlm-1298	15	119	-	-	ADJ
ajlm-1298	15	120	severe	severe	ADJ
ajlm-1298	15	121	cases	case	NOUN
ajlm-1298	15	122	,	,	PUNCT
ajlm-1298	15	123	demonstrating	demonstrate	VERB
ajlm-1298	15	124	that	that	SCONJ
ajlm-1298	15	125	high	high	ADJ
ajlm-1298	15	126	d	d	NOUN
ajlm-1298	15	127	-	-	PUNCT
ajlm-1298	15	128	dimer	dimer	NOUN
ajlm-1298	15	129	and	and	CCONJ
ajlm-1298	15	130	c	c	NOUN
ajlm-1298	15	131	-	-	PUNCT
ajlm-1298	15	132	reactive	reactive	ADJ
ajlm-1298	15	133	protein	protein	NOUN
ajlm-1298	15	134	levels	level	NOUN
ajlm-1298	15	135	were	be	AUX
ajlm-1298	15	136	significantly	significantly	ADV
ajlm-1298	15	137	associated	associate	VERB
ajlm-1298	15	138	with	with	ADP
ajlm-1298	15	139	covid-19	covid-19	PROPN
ajlm-1298	15	140	severity.5	severity.5	PROPN
ajlm-1298	15	141	additionally	additionally	ADV
ajlm-1298	15	142	,	,	PUNCT
ajlm-1298	15	143	in	in	ADP
ajlm-1298	15	144	wuhan	wuhan	PROPN
ajlm-1298	15	145	jinyintan	jinyintan	PROPN
ajlm-1298	15	146	hospital	hospital	PROPN
ajlm-1298	15	147	,	,	PUNCT
ajlm-1298	15	148	china	china	PROPN
ajlm-1298	15	149	,	,	PUNCT
ajlm-1298	15	150	a	a	DET
ajlm-1298	15	151	study	study	NOUN
ajlm-1298	15	152	showed	show	VERB
ajlm-1298	15	153	that	that	SCONJ
ajlm-1298	15	154	high	high	ADJ
ajlm-1298	15	155	levels	level	NOUN
ajlm-1298	15	156	of	of	ADP
ajlm-1298	15	157	interleukin-6	interleukin-6	NUM
ajlm-1298	15	158	were	be	AUX
ajlm-1298	15	159	significantly	significantly	ADV
ajlm-1298	15	160	associated	associate	VERB
ajlm-1298	15	161	with	with	ADP
ajlm-1298	15	162	a	a	DET
ajlm-1298	15	163	high	high	ADJ
ajlm-1298	15	164	mortality	mortality	NOUN
ajlm-1298	15	165	rate.6	rate.6	NOUN
ajlm-1298	15	166	this	this	DET
ajlm-1298	15	167	finding	finding	NOUN
ajlm-1298	15	168	was	be	AUX
ajlm-1298	15	169	corroborated	corroborate	VERB
ajlm-1298	15	170	by	by	ADP
ajlm-1298	15	171	silberstein	silberstein	NOUN
ajlm-1298	15	172	in	in	ADP
ajlm-1298	15	173	this	this	DET
ajlm-1298	15	174	study.7	study.7	NOUN
ajlm-1298	15	175	liu	liu	PROPN
ajlm-1298	15	176	y	y	PROPN
ajlm-1298	15	177	et	et	PROPN
ajlm-1298	15	178	al	al	PROPN
ajlm-1298	15	179	.	.	PROPN
ajlm-1298	16	1	in	in	ADP
ajlm-1298	16	2	zhongnan	zhongnan	PROPN
ajlm-1298	16	3	hospital	hospital	PROPN
ajlm-1298	16	4	of	of	ADP
ajlm-1298	16	5	wuhan	wuhan	PROPN
ajlm-1298	16	6	university	university	PROPN
ajlm-1298	16	7	identified	identify	VERB
ajlm-1298	16	8	an	an	DET
ajlm-1298	16	9	elevation	elevation	NOUN
ajlm-1298	16	10	in	in	ADP
ajlm-1298	16	11	the	the	DET
ajlm-1298	16	12	neutrophil	neutrophil	NOUN
ajlm-1298	16	13	-	-	PUNCT
ajlm-1298	16	14	to	to	ADP
ajlm-1298	16	15	-	-	PUNCT
ajlm-1298	16	16	lymphocyte	lymphocyte	NOUN
ajlm-1298	16	17	ratio	ratio	NOUN
ajlm-1298	16	18	as	as	ADP
ajlm-1298	16	19	an	an	DET
ajlm-1298	16	20	independent	independent	ADJ
ajlm-1298	16	21	and	and	CCONJ
ajlm-1298	16	22	significant	significant	ADJ
ajlm-1298	16	23	predictor	predictor	NOUN
ajlm-1298	16	24	of	of	ADP
ajlm-1298	16	25	mortality	mortality	NOUN
ajlm-1298	16	26	among	among	ADP
ajlm-1298	16	27	245	245	NUM
ajlm-1298	16	28	hospitalised	hospitalise	VERB
ajlm-1298	16	29	covid-19	covid-19	PROPN
ajlm-1298	16	30	patients	patient	NOUN
ajlm-1298	16	31	,	,	PUNCT
ajlm-1298	16	32	with	with	ADP
ajlm-1298	16	33	an	an	DET
ajlm-1298	16	34	8	8	NUM
ajlm-1298	16	35	%	%	NOUN
ajlm-1298	16	36	increase	increase	NOUN
ajlm-1298	16	37	in	in	ADP
ajlm-1298	16	38	mortality	mortality	NOUN
ajlm-1298	16	39	with	with	ADP
ajlm-1298	16	40	each	each	DET
ajlm-1298	16	41	unit	unit	NOUN
ajlm-1298	16	42	increase	increase	VERB
ajlm-1298	16	43	in	in	ADP
ajlm-1298	16	44	neutrophil	neutrophil	ADJ
ajlm-1298	16	45	-	-	PUNCT
ajlm-1298	16	46	to	to	ADP
ajlm-1298	16	47	-	-	PUNCT
ajlm-1298	16	48	lymphocyte	lymphocyte	ADJ
ajlm-1298	16	49	ratio.8	ratio.8	NOUN
ajlm-1298	16	50	many	many	ADJ
ajlm-1298	16	51	studies	study	NOUN
ajlm-1298	16	52	reported	report	VERB
ajlm-1298	16	53	a	a	DET
ajlm-1298	16	54	correlation	correlation	NOUN
ajlm-1298	16	55	between	between	ADP
ajlm-1298	16	56	high	high	ADJ
ajlm-1298	16	57	levels	level	NOUN
ajlm-1298	16	58	of	of	ADP
ajlm-1298	16	59	hs	hs	PROPN
ajlm-1298	16	60	-	-	PROPN
ajlm-1298	16	61	crp	crp	PROPN
ajlm-1298	16	62	and	and	CCONJ
ajlm-1298	16	63	mortality	mortality	NOUN
ajlm-1298	16	64	rate	rate	NOUN
ajlm-1298	16	65	in	in	ADP
ajlm-1298	16	66	covid-19	covid-19	PROPN
ajlm-1298	16	67	patients	patient	NOUN
ajlm-1298	16	68	.	.	PUNCT
ajlm-1298	17	1	a	a	DET
ajlm-1298	17	2	study	study	NOUN
ajlm-1298	17	3	done	do	VERB
ajlm-1298	17	4	among	among	ADP
ajlm-1298	17	5	375	375	NUM
ajlm-1298	17	6	patients	patient	NOUN
ajlm-1298	17	7	with	with	ADP
ajlm-1298	17	8	confirmed	confirm	VERB
ajlm-1298	17	9	sars	sar	NOUN
ajlm-1298	17	10	-	-	PUNCT
ajlm-1298	17	11	cov-2	cov-2	PART
ajlm-1298	17	12	infection	infection	NOUN
ajlm-1298	17	13	revealed	reveal	VERB
ajlm-1298	17	14	that	that	SCONJ
ajlm-1298	17	15	elevated	elevate	VERB
ajlm-1298	17	16	hs	hs	PROPN
ajlm-1298	17	17	-	-	PROPN
ajlm-1298	17	18	crp	crp	PROPN
ajlm-1298	17	19	levels	level	NOUN
ajlm-1298	17	20	were	be	AUX
ajlm-1298	17	21	significantly	significantly	ADV
ajlm-1298	17	22	associated	associate	VERB
ajlm-1298	17	23	with	with	ADP
ajlm-1298	17	24	a	a	DET
ajlm-1298	17	25	high	high	ADJ
ajlm-1298	17	26	mortality	mortality	NOUN
ajlm-1298	17	27	risk.9	risk.9	PROPN
ajlm-1298	17	28	in	in	ADP
ajlm-1298	17	29	another	another	DET
ajlm-1298	17	30	study	study	NOUN
ajlm-1298	17	31	conducted	conduct	VERB
ajlm-1298	17	32	to	to	PART
ajlm-1298	17	33	evaluate	evaluate	VERB
ajlm-1298	17	34	fatal	fatal	ADJ
ajlm-1298	17	35	outcomes	outcome	NOUN
ajlm-1298	17	36	among	among	ADP
ajlm-1298	17	37	covid-19	covid-19	PROPN
ajlm-1298	17	38	patients	patient	NOUN
ajlm-1298	17	39	,	,	PUNCT
ajlm-1298	17	40	187	187	NUM
ajlm-1298	17	41	patients	patient	NOUN
ajlm-1298	17	42	from	from	ADP
ajlm-1298	17	43	china	china	PROPN
ajlm-1298	17	44	were	be	AUX
ajlm-1298	17	45	included	include	VERB
ajlm-1298	17	46	among	among	ADP
ajlm-1298	17	47	whom	whom	PRON
ajlm-1298	17	48	43	43	NUM
ajlm-1298	17	49	died	die	VERB
ajlm-1298	17	50	,	,	PUNCT
ajlm-1298	17	51	and	and	CCONJ
ajlm-1298	17	52	results	result	NOUN
ajlm-1298	17	53	revealed	reveal	VERB
ajlm-1298	17	54	that	that	SCONJ
ajlm-1298	17	55	high	high	ADJ
ajlm-1298	17	56	levels	level	NOUN
ajlm-1298	17	57	of	of	ADP
ajlm-1298	17	58	hs	hs	PROPN
ajlm-1298	17	59	-	-	PROPN
ajlm-1298	17	60	crp	crp	PROPN
ajlm-1298	17	61	was	be	AUX
ajlm-1298	17	62	significantly	significantly	ADV
ajlm-1298	17	63	associated	associate	VERB
ajlm-1298	17	64	with	with	ADP
ajlm-1298	17	65	mortality.10	mortality.10	NOUN
ajlm-1298	17	66	we	we	PRON
ajlm-1298	17	67	conclude	conclude	VERB
ajlm-1298	17	68	that	that	DET
ajlm-1298	17	69	elevation	elevation	NOUN
ajlm-1298	17	70	in	in	ADP
ajlm-1298	17	71	levels	level	NOUN
ajlm-1298	17	72	of	of	ADP
ajlm-1298	17	73	these	these	DET
ajlm-1298	17	74	four	four	NUM
ajlm-1298	17	75	inflammatory	inflammatory	ADJ
ajlm-1298	17	76	markers	marker	NOUN
ajlm-1298	17	77	may	may	AUX
ajlm-1298	17	78	be	be	AUX
ajlm-1298	17	79	indicative	indicative	ADJ
ajlm-1298	17	80	of	of	ADP
ajlm-1298	17	81	covid-19	covid-19	PROPN
ajlm-1298	17	82	infection	infection	NOUN
ajlm-1298	17	83	severity	severity	NOUN
ajlm-1298	17	84	and	and	CCONJ
ajlm-1298	17	85	mortality	mortality	NOUN
ajlm-1298	17	86	.	.	PUNCT
ajlm-1298	18	1	we	we	PRON
ajlm-1298	18	2	suggest	suggest	VERB
ajlm-1298	18	3	that	that	SCONJ
ajlm-1298	18	4	these	these	DET
ajlm-1298	18	5	parameters	parameter	NOUN
ajlm-1298	18	6	may	may	AUX
ajlm-1298	18	7	be	be	AUX
ajlm-1298	18	8	helpful	helpful	ADJ
ajlm-1298	18	9	predictors	predictor	NOUN
ajlm-1298	18	10	of	of	ADP
ajlm-1298	18	11	covid-19	covid-19	PROPN
ajlm-1298	18	12	severity	severity	NOUN
ajlm-1298	18	13	and	and	CCONJ
ajlm-1298	18	14	could	could	AUX
ajlm-1298	18	15	be	be	AUX
ajlm-1298	18	16	used	use	VERB
ajlm-1298	18	17	as	as	ADP
ajlm-1298	18	18	early	early	ADJ
ajlm-1298	18	19	predictors	predictor	NOUN
ajlm-1298	18	20	for	for	ADP
ajlm-1298	18	21	case	case	NOUN
ajlm-1298	18	22	management	management	NOUN
ajlm-1298	18	23	before	before	ADP
ajlm-1298	18	24	deterioration	deterioration	NOUN
ajlm-1298	18	25	.	.	PUNCT
ajlm-1298	19	1	on	on	ADP
ajlm-1298	19	2	the	the	DET
ajlm-1298	19	3	other	other	ADJ
ajlm-1298	19	4	hand	hand	NOUN
ajlm-1298	19	5	,	,	PUNCT
ajlm-1298	19	6	these	these	DET
ajlm-1298	19	7	parameters	parameter	NOUN
ajlm-1298	19	8	can	can	AUX
ajlm-1298	19	9	not	not	PART
ajlm-1298	19	10	be	be	AUX
ajlm-1298	19	11	used	use	VERB
ajlm-1298	19	12	independently	independently	ADV
ajlm-1298	19	13	for	for	ADP
ajlm-1298	19	14	initial	initial	ADJ
ajlm-1298	19	15	diagnosis	diagnosis	NOUN
ajlm-1298	19	16	and	and	CCONJ
ajlm-1298	19	17	physicians	physician	NOUN
ajlm-1298	19	18	need	need	VERB
ajlm-1298	19	19	to	to	PART
ajlm-1298	19	20	monitor	monitor	VERB
ajlm-1298	19	21	the	the	DET
ajlm-1298	19	22	presence	presence	NOUN
ajlm-1298	19	23	of	of	ADP
ajlm-1298	19	24	other	other	ADJ
ajlm-1298	19	25	infections	infection	NOUN
ajlm-1298	19	26	that	that	PRON
ajlm-1298	19	27	may	may	AUX
ajlm-1298	19	28	interfere	interfere	VERB
ajlm-1298	19	29	with	with	ADP
ajlm-1298	19	30	the	the	DET
ajlm-1298	19	31	elevation	elevation	NOUN
ajlm-1298	19	32	of	of	ADP
ajlm-1298	19	33	these	these	DET
ajlm-1298	19	34	markers	marker	NOUN
ajlm-1298	19	35	.	.	PUNCT
ajlm-1298	20	1	finally	finally	ADV
ajlm-1298	20	2	,	,	PUNCT
ajlm-1298	20	3	we	we	PRON
ajlm-1298	20	4	recommend	recommend	VERB
ajlm-1298	20	5	that	that	SCONJ
ajlm-1298	20	6	similar	similar	ADJ
ajlm-1298	20	7	studies	study	NOUN
ajlm-1298	20	8	on	on	ADP
ajlm-1298	20	9	inflammatory	inflammatory	ADJ
ajlm-1298	20	10	markers	marker	NOUN
ajlm-1298	20	11	should	should	AUX
ajlm-1298	20	12	be	be	AUX
ajlm-1298	20	13	conducted	conduct	VERB
ajlm-1298	20	14	in	in	ADP
ajlm-1298	20	15	african	african	ADJ
ajlm-1298	20	16	populations	population	NOUN
ajlm-1298	20	17	to	to	PART
ajlm-1298	20	18	demonstrate	demonstrate	VERB
ajlm-1298	20	19	the	the	DET
ajlm-1298	20	20	levels	level	NOUN
ajlm-1298	20	21	of	of	ADP
ajlm-1298	20	22	these	these	DET
ajlm-1298	20	23	markers	marker	NOUN
ajlm-1298	20	24	among	among	ADP
ajlm-1298	20	25	african	african	ADJ
ajlm-1298	20	26	covid-19	covid-19	PROPN
ajlm-1298	20	27	patients	patient	NOUN
ajlm-1298	20	28	and	and	CCONJ
ajlm-1298	20	29	their	their	PRON
ajlm-1298	20	30	association	association	NOUN
ajlm-1298	20	31	with	with	ADP
ajlm-1298	20	32	covid-19	covid-19	PROPN
ajlm-1298	20	33	severity	severity	NOUN
ajlm-1298	20	34	and	and	CCONJ
ajlm-1298	20	35	mortality	mortality	NOUN
ajlm-1298	20	36	.	.	PUNCT
ajlm-1298	21	1	acknowledgements	acknowledgement	NOUN
ajlm-1298	21	2	competing	compete	VERB
ajlm-1298	21	3	interests	interest	NOUN
ajlm-1298	21	4	the	the	DET
ajlm-1298	21	5	authors	author	NOUN
ajlm-1298	21	6	have	have	AUX
ajlm-1298	21	7	declared	declare	VERB
ajlm-1298	21	8	that	that	SCONJ
ajlm-1298	21	9	no	no	DET
ajlm-1298	21	10	competing	compete	VERB
ajlm-1298	21	11	interests	interest	NOUN
ajlm-1298	21	12	exist	exist	VERB
ajlm-1298	21	13	.	.	PUNCT
ajlm-1298	22	1	authors	author	NOUN
ajlm-1298	22	2	’	’	PART
ajlm-1298	22	3	contributions	contribution	NOUN
ajlm-1298	22	4	a.a.a	a.a.a	PROPN
ajlm-1298	22	5	.	.	PUNCT
ajlm-1298	22	6	,	,	PUNCT
ajlm-1298	22	7	a.m.	a.m.	ADV
ajlm-1298	22	8	,	,	PUNCT
ajlm-1298	22	9	a.a.e	a.a.e	PROPN
ajlm-1298	22	10	.	.	PUNCT
ajlm-1298	23	1	and	and	CCONJ
ajlm-1298	23	2	i.a.a	i.a.a	PROPN
ajlm-1298	23	3	.	.	PROPN
ajlm-1298	23	4	developed	develop	VERB
ajlm-1298	23	5	the	the	DET
ajlm-1298	23	6	concepts	concept	NOUN
ajlm-1298	23	7	and	and	CCONJ
ajlm-1298	23	8	performed	perform	VERB
ajlm-1298	23	9	the	the	DET
ajlm-1298	23	10	literature	literature	NOUN
ajlm-1298	23	11	search	search	NOUN
ajlm-1298	23	12	.	.	PUNCT
ajlm-1298	24	1	m.o.h	m.o.h	PROPN
ajlm-1298	24	2	.	.	PUNCT
ajlm-1298	25	1	and	and	CCONJ
ajlm-1298	25	2	m.a	m.a	PROPN
ajlm-1298	25	3	.	.	PROPN
ajlm-1298	25	4	helped	help	VERB
ajlm-1298	25	5	to	to	PART
ajlm-1298	25	6	supervise	supervise	VERB
ajlm-1298	25	7	the	the	DET
ajlm-1298	25	8	project	project	NOUN
ajlm-1298	25	9	.	.	PUNCT
ajlm-1298	26	1	a.h.a	a.h.a	ADJ
ajlm-1298	26	2	and	and	CCONJ
ajlm-1298	26	3	r.b.g	r.b.g	ADJ
ajlm-1298	26	4	.	.	PROPN
ajlm-1298	26	5	edited	edit	VERB
ajlm-1298	26	6	the	the	DET
ajlm-1298	26	7	manuscript	manuscript	NOUN
ajlm-1298	26	8	.	.	PUNCT
ajlm-1298	27	1	a.a.a	a.a.a	PROPN
ajlm-1298	27	2	.	.	PROPN
ajlm-1298	27	3	,	,	PUNCT
ajlm-1298	27	4	a.h.a	a.h.a	PROPN
ajlm-1298	27	5	.	.	PUNCT
ajlm-1298	27	6	and	and	CCONJ
ajlm-1298	27	7	a.a.e	a.a.e	PROPN
ajlm-1298	27	8	.	.	PUNCT
ajlm-1298	28	1	prepared	prepare	VERB
ajlm-1298	28	2	and	and	CCONJ
ajlm-1298	28	3	reviewed	review	VERB
ajlm-1298	28	4	the	the	DET
ajlm-1298	28	5	manuscript	manuscript	NOUN
ajlm-1298	28	6	.	.	PUNCT
ajlm-1298	29	1	h.s.a	h.s.a	PROPN
ajlm-1298	29	2	.	.	PROPN
ajlm-1298	29	3	helped	help	VERB
ajlm-1298	29	4	in	in	ADP
ajlm-1298	29	5	writing	write	VERB
ajlm-1298	29	6	the	the	DET
ajlm-1298	29	7	literature	literature	PROPN
ajlm-1298	29	8	review	review	NOUN
ajlm-1298	29	9	.	.	PUNCT
ajlm-1298	30	1	m.a	m.a	PROPN
ajlm-1298	30	2	.	.	PROPN
ajlm-1298	30	3	and	and	CCONJ
ajlm-1298	30	4	m.o.h	m.o.h	ADJ
ajlm-1298	30	5	.	.	PROPN
ajlm-1298	30	6	were	be	AUX
ajlm-1298	30	7	responsible	responsible	ADJ
ajlm-1298	30	8	for	for	ADP
ajlm-1298	30	9	final	final	ADJ
ajlm-1298	30	10	approval	approval	NOUN
ajlm-1298	30	11	of	of	ADP
ajlm-1298	30	12	the	the	DET
ajlm-1298	30	13	version	version	NOUN
ajlm-1298	30	14	to	to	PART
ajlm-1298	30	15	be	be	AUX
ajlm-1298	30	16	published	publish	VERB
ajlm-1298	30	17	.	.	PUNCT
ajlm-1298	31	1	ethical	ethical	ADJ
ajlm-1298	31	2	considerations	consideration	NOUN
ajlm-1298	31	3	this	this	DET
ajlm-1298	31	4	article	article	NOUN
ajlm-1298	31	5	followed	follow	VERB
ajlm-1298	31	6	all	all	DET
ajlm-1298	31	7	ethical	ethical	ADJ
ajlm-1298	31	8	standards	standard	NOUN
ajlm-1298	31	9	for	for	ADP
ajlm-1298	31	10	research	research	NOUN
ajlm-1298	31	11	without	without	ADP
ajlm-1298	31	12	direct	direct	ADJ
ajlm-1298	31	13	contact	contact	NOUN
ajlm-1298	31	14	with	with	ADP
ajlm-1298	31	15	human	human	ADJ
ajlm-1298	31	16	or	or	CCONJ
ajlm-1298	31	17	animal	animal	NOUN
ajlm-1298	31	18	subjects	subject	NOUN
ajlm-1298	31	19	.	.	PUNCT
ajlm-1298	32	1	sources	source	NOUN
ajlm-1298	32	2	of	of	ADP
ajlm-1298	32	3	support	support	NOUN
ajlm-1298	32	4	this	this	DET
ajlm-1298	32	5	research	research	NOUN
ajlm-1298	32	6	received	receive	VERB
ajlm-1298	32	7	no	no	DET
ajlm-1298	32	8	specific	specific	ADJ
ajlm-1298	32	9	grant	grant	NOUN
ajlm-1298	32	10	from	from	ADP
ajlm-1298	32	11	any	any	DET
ajlm-1298	32	12	funding	funding	NOUN
ajlm-1298	32	13	agency	agency	NOUN
ajlm-1298	32	14	in	in	ADP
ajlm-1298	32	15	the	the	DET
ajlm-1298	32	16	public	public	ADJ
ajlm-1298	32	17	,	,	PUNCT
ajlm-1298	32	18	commercial	commercial	ADJ
ajlm-1298	32	19	or	or	CCONJ
ajlm-1298	32	20	not	not	PART
ajlm-1298	32	21	-	-	PUNCT
ajlm-1298	32	22	for	for	ADP
ajlm-1298	32	23	-	-	PUNCT
ajlm-1298	32	24	profit	profit	NOUN
ajlm-1298	32	25	sectors	sector	NOUN
ajlm-1298	32	26	.	.	PUNCT
ajlm-1298	33	1	data	datum	NOUN
ajlm-1298	33	2	availability	availability	NOUN
ajlm-1298	33	3	statement	statement	NOUN
ajlm-1298	33	4	data	datum	NOUN
ajlm-1298	33	5	sharing	sharing	NOUN
ajlm-1298	33	6	is	be	AUX
ajlm-1298	33	7	not	not	PART
ajlm-1298	33	8	applicable	applicable	ADJ
ajlm-1298	33	9	to	to	ADP
ajlm-1298	33	10	this	this	DET
ajlm-1298	33	11	article	article	NOUN
ajlm-1298	33	12	as	as	SCONJ
ajlm-1298	33	13	no	no	DET
ajlm-1298	33	14	new	new	ADJ
ajlm-1298	33	15	data	datum	NOUN
ajlm-1298	33	16	were	be	AUX
ajlm-1298	33	17	created	create	VERB
ajlm-1298	33	18	or	or	CCONJ
ajlm-1298	33	19	analysed	analyse	VERB
ajlm-1298	33	20	in	in	ADP
ajlm-1298	33	21	this	this	DET
ajlm-1298	33	22	study	study	NOUN
ajlm-1298	33	23	.	.	PUNCT
ajlm-1298	34	1	disclaimer	disclaimer	VERB
ajlm-1298	34	2	the	the	DET
ajlm-1298	34	3	views	view	NOUN
ajlm-1298	34	4	and	and	CCONJ
ajlm-1298	34	5	opinions	opinion	NOUN
ajlm-1298	34	6	expressed	express	VERB
ajlm-1298	34	7	in	in	ADP
ajlm-1298	34	8	this	this	DET
ajlm-1298	34	9	article	article	NOUN
ajlm-1298	34	10	are	be	AUX
ajlm-1298	34	11	those	those	PRON
ajlm-1298	34	12	of	of	ADP
ajlm-1298	34	13	the	the	DET
ajlm-1298	34	14	authors	author	NOUN
ajlm-1298	34	15	and	and	CCONJ
ajlm-1298	34	16	do	do	AUX
ajlm-1298	34	17	not	not	PART
ajlm-1298	34	18	necessarily	necessarily	ADV
ajlm-1298	34	19	reflect	reflect	VERB
ajlm-1298	34	20	the	the	DET
ajlm-1298	34	21	official	official	ADJ
ajlm-1298	34	22	policy	policy	NOUN
ajlm-1298	34	23	or	or	CCONJ
ajlm-1298	34	24	position	position	NOUN
ajlm-1298	34	25	of	of	ADP
ajlm-1298	34	26	any	any	DET
ajlm-1298	34	27	affiliated	affiliated	ADJ
ajlm-1298	34	28	agency	agency	NOUN
ajlm-1298	34	29	of	of	ADP
ajlm-1298	34	30	the	the	DET
ajlm-1298	34	31	authors	author	NOUN
ajlm-1298	34	32	.	.	PUNCT
ajlm-1298	35	1	references	reference	NOUN
ajlm-1298	35	2	qin	qin	PROPN
ajlm-1298	36	1	c	c	X
ajlm-1298	36	2	,	,	PUNCT
ajlm-1298	36	3	zhou	zhou	PROPN
ajlm-1298	36	4	l	l	PROPN
ajlm-1298	36	5	,	,	PUNCT
ajlm-1298	36	6	hu	hu	PROPN
ajlm-1298	37	1	z	z	X
ajlm-1298	37	2	,	,	PUNCT
ajlm-1298	37	3	et	et	PROPN
ajlm-1298	37	4	al	al	PROPN
ajlm-1298	37	5	.	.	PROPN
ajlm-1298	37	6	dysregulation	dysregulation	NOUN
ajlm-1298	37	7	of	of	ADP
ajlm-1298	37	8	immune	immune	ADJ
ajlm-1298	37	9	response	response	NOUN
ajlm-1298	37	10	in	in	ADP
ajlm-1298	37	11	patients	patient	NOUN
ajlm-1298	37	12	with	with	ADP
ajlm-1298	37	13	covid-19	covid-19	PROPN
ajlm-1298	37	14	in	in	ADP
ajlm-1298	37	15	wuhan	wuhan	PROPN
ajlm-1298	37	16	,	,	PUNCT
ajlm-1298	37	17	china	china	PROPN
ajlm-1298	37	18	.	.	PUNCT
ajlm-1298	38	1	clin	clin	PROPN
ajlm-1298	38	2	infect	infect	PROPN
ajlm-1298	38	3	dis	dis	PROPN
ajlm-1298	38	4	.	.	PUNCT
ajlm-1298	39	1	2020;71(15):762–768	2020;71(15):762–768	NUM
ajlm-1298	39	2	.	.	PUNCT
ajlm-1298	40	1	https://doi.org/10.1093/cid/ciaa248	https://doi.org/10.1093/cid/ciaa248	PROPN
ajlm-1298	40	2	chen	chen	PROPN
ajlm-1298	40	3	n	n	CCONJ
ajlm-1298	40	4	,	,	PUNCT
ajlm-1298	40	5	zhou	zhou	PROPN
ajlm-1298	40	6	m	m	PROPN
ajlm-1298	40	7	,	,	PUNCT
ajlm-1298	40	8	dong	dong	PROPN
ajlm-1298	40	9	x	x	PROPN
ajlm-1298	40	10	,	,	PUNCT
ajlm-1298	40	11	et	et	PROPN
ajlm-1298	40	12	al	al	PROPN
ajlm-1298	40	13	.	.	PROPN
ajlm-1298	40	14	epidemiological	epidemiological	ADJ
ajlm-1298	40	15	and	and	CCONJ
ajlm-1298	40	16	clinical	clinical	ADJ
ajlm-1298	40	17	characteristics	characteristic	NOUN
ajlm-1298	40	18	of	of	ADP
ajlm-1298	40	19	99	99	NUM
ajlm-1298	40	20	cases	case	NOUN
ajlm-1298	40	21	of	of	ADP
ajlm-1298	40	22	2019	2019	NUM
ajlm-1298	40	23	novel	novel	ADJ
ajlm-1298	40	24	coronavirus	coronavirus	NOUN
ajlm-1298	40	25	pneumonia	pneumonia	NOUN
ajlm-1298	40	26	in	in	ADP
ajlm-1298	40	27	wuhan	wuhan	PROPN
ajlm-1298	40	28	,	,	PUNCT
ajlm-1298	40	29	china	china	PROPN
ajlm-1298	40	30	:	:	PUNCT
ajlm-1298	40	31	a	a	DET
ajlm-1298	40	32	descriptive	descriptive	ADJ
ajlm-1298	40	33	study	study	NOUN
ajlm-1298	40	34	.	.	PUNCT
ajlm-1298	41	1	lancet	lancet	PROPN
ajlm-1298	41	2	.	.	PUNCT
ajlm-1298	42	1	2020	2020	NUM
ajlm-1298	42	2	feb	feb	PROPN
ajlm-1298	42	3	15;395(10223):507–513	15;395(10223):507–513	NUM
ajlm-1298	42	4	.	.	PUNCT
ajlm-1298	43	1	https://doi.org/10.1016/s0140-6736(20)30211-7	https://doi.org/10.1016/s0140-6736(20)30211-7	VERB
ajlm-1298	43	2	zhou	zhou	PROPN
ajlm-1298	44	1	f	f	PROPN
ajlm-1298	44	2	,	,	PUNCT
ajlm-1298	44	3	yu	yu	PROPN
ajlm-1298	44	4	t	t	PROPN
ajlm-1298	44	5	,	,	PUNCT
ajlm-1298	44	6	du	du	PROPN
ajlm-1298	44	7	r	r	PROPN
ajlm-1298	44	8	,	,	PUNCT
ajlm-1298	44	9	et	et	PROPN
ajlm-1298	44	10	al	al	PROPN
ajlm-1298	44	11	.	.	PUNCT
ajlm-1298	45	1	clinical	clinical	ADJ
ajlm-1298	45	2	course	course	NOUN
ajlm-1298	45	3	and	and	CCONJ
ajlm-1298	45	4	risk	risk	NOUN
ajlm-1298	45	5	factors	factor	NOUN
ajlm-1298	45	6	for	for	ADP
ajlm-1298	45	7	mortality	mortality	NOUN
ajlm-1298	45	8	of	of	ADP
ajlm-1298	45	9	adult	adult	NOUN
ajlm-1298	45	10	inpatients	inpatient	NOUN
ajlm-1298	45	11	with	with	ADP
ajlm-1298	45	12	covid-19	covid-19	PROPN
ajlm-1298	45	13	in	in	ADP
ajlm-1298	45	14	wuhan	wuhan	PROPN
ajlm-1298	45	15	,	,	PUNCT
ajlm-1298	45	16	china	china	PROPN
ajlm-1298	45	17	:	:	PUNCT
ajlm-1298	45	18	a	a	DET
ajlm-1298	45	19	retrospective	retrospective	ADJ
ajlm-1298	45	20	cohort	cohort	NOUN
ajlm-1298	45	21	study	study	NOUN
ajlm-1298	45	22	.	.	PUNCT
ajlm-1298	46	1	lancet	lancet	PROPN
ajlm-1298	46	2	.	.	PUNCT
ajlm-1298	47	1	2020;395(10229):1054–1062	2020;395(10229):1054–1062	NUM
ajlm-1298	47	2	.	.	PUNCT
ajlm-1298	48	1	https://doi.org/10.1016/s0140-6736(20)30566-3	https://doi.org/10.1016/s0140-6736(20)30566-3	PROPN
ajlm-1298	48	2	zhang	zhang	PROPN
ajlm-1298	48	3	l	l	PROPN
ajlm-1298	48	4	,	,	PUNCT
ajlm-1298	48	5	yan	yan	PROPN
ajlm-1298	48	6	x	x	SYM
ajlm-1298	48	7	,	,	PUNCT
ajlm-1298	48	8	fan	fan	PROPN
ajlm-1298	48	9	q	q	PROPN
ajlm-1298	48	10	,	,	PUNCT
ajlm-1298	48	11	et	et	PROPN
ajlm-1298	48	12	al	al	PROPN
ajlm-1298	48	13	.	.	PUNCT
ajlm-1298	49	1	d	d	X
ajlm-1298	49	2	-	-	PUNCT
ajlm-1298	49	3	dimer	dimer	ADJ
ajlm-1298	49	4	levels	level	NOUN
ajlm-1298	49	5	on	on	ADP
ajlm-1298	49	6	admission	admission	NOUN
ajlm-1298	49	7	to	to	PART
ajlm-1298	49	8	predict	predict	VERB
ajlm-1298	49	9	in	in	ADP
ajlm-1298	49	10	hospital	hospital	NOUN
ajlm-1298	49	11	mortality	mortality	NOUN
ajlm-1298	49	12	in	in	ADP
ajlm-1298	49	13	patients	patient	NOUN
ajlm-1298	49	14	with	with	ADP
ajlm-1298	49	15	covid-19	covid-19	PROPN
ajlm-1298	49	16	.	.	PUNCT
ajlm-1298	50	1	j	j	PROPN
ajlm-1298	50	2	thromb	thromb	PROPN
ajlm-1298	50	3	haemost	haemost	PROPN
ajlm-1298	50	4	.	.	PUNCT
ajlm-1298	51	1	2020	2020	NUM
ajlm-1298	51	2	jun;18(6):1324–1329	jun;18(6):1324–1329	X
ajlm-1298	51	3	.	.	PUNCT
ajlm-1298	52	1	https://doi.org/10.1111/jth.14859	https://doi.org/10.1111/jth.14859	PROPN
ajlm-1298	52	2	guan	guan	PROPN
ajlm-1298	52	3	wj	wj	PROPN
ajlm-1298	52	4	,	,	PUNCT
ajlm-1298	52	5	ni	ni	PROPN
ajlm-1298	52	6	zy	zy	PROPN
ajlm-1298	52	7	,	,	PUNCT
ajlm-1298	52	8	hu	hu	PROPN
ajlm-1298	52	9	y	y	PROPN
ajlm-1298	52	10	,	,	PUNCT
ajlm-1298	52	11	et	et	PROPN
ajlm-1298	52	12	al	al	PROPN
ajlm-1298	52	13	.	.	PROPN
ajlm-1298	53	1	clinical	clinical	ADJ
ajlm-1298	53	2	characteristics	characteristic	NOUN
ajlm-1298	53	3	of	of	ADP
ajlm-1298	53	4	coronavirus	coronavirus	NOUN
ajlm-1298	53	5	disease	disease	NOUN
ajlm-1298	53	6	2019	2019	NUM
ajlm-1298	53	7	in	in	ADP
ajlm-1298	53	8	china	china	PROPN
ajlm-1298	53	9	.	.	PUNCT
ajlm-1298	54	1	n	n	PROPN
ajlm-1298	54	2	engl	engl	PROPN
ajlm-1298	54	3	j	j	PROPN
ajlm-1298	54	4	med	med	PROPN
ajlm-1298	54	5	.	.	PUNCT
ajlm-1298	55	1	2020	2020	NUM
ajlm-1298	55	2	apr	apr	VERB
ajlm-1298	55	3	30;382(18):1708–1720	30;382(18):1708–1720	NUM
ajlm-1298	55	4	.	.	PUNCT
ajlm-1298	56	1	wu	wu	PROPN
ajlm-1298	56	2	c	c	PROPN
ajlm-1298	56	3	,	,	PUNCT
ajlm-1298	56	4	chen	chen	PROPN
ajlm-1298	56	5	x	x	PROPN
ajlm-1298	56	6	,	,	PUNCT
ajlm-1298	56	7	cai	cai	PROPN
ajlm-1298	56	8	y	y	PROPN
ajlm-1298	56	9	,	,	PUNCT
ajlm-1298	56	10	et	et	PROPN
ajlm-1298	56	11	al	al	PROPN
ajlm-1298	56	12	.	.	PUNCT
ajlm-1298	57	1	risk	risk	NOUN
ajlm-1298	57	2	factors	factor	NOUN
ajlm-1298	57	3	associated	associate	VERB
ajlm-1298	57	4	with	with	ADP
ajlm-1298	57	5	acute	acute	ADJ
ajlm-1298	57	6	respiratory	respiratory	ADJ
ajlm-1298	57	7	distress	distress	NOUN
ajlm-1298	57	8	syndrome	syndrome	NOUN
ajlm-1298	57	9	and	and	CCONJ
ajlm-1298	57	10	death	death	NOUN
ajlm-1298	57	11	in	in	ADP
ajlm-1298	57	12	patients	patient	NOUN
ajlm-1298	57	13	with	with	ADP
ajlm-1298	57	14	coronavirus	coronavirus	NOUN
ajlm-1298	57	15	disease	disease	NOUN
ajlm-1298	57	16	2019	2019	NUM
ajlm-1298	57	17	pneumonia	pneumonia	NOUN
ajlm-1298	57	18	in	in	ADP
ajlm-1298	57	19	wuhan	wuhan	PROPN
ajlm-1298	57	20	,	,	PUNCT
ajlm-1298	57	21	china	china	PROPN
ajlm-1298	57	22	.	.	PROPN
ajlm-1298	58	1	jama	jama	PROPN
ajlm-1298	58	2	intern	intern	PROPN
ajlm-1298	58	3	med	me	VERB
ajlm-1298	58	4	.	.	PUNCT
ajlm-1298	59	1	2020;180(7):934–943	2020;180(7):934–943	NUM
ajlm-1298	59	2	.	.	PUNCT
ajlm-1298	60	1	https://doi.org/10.1001/jamainternmed.2020.0994	https://doi.org/10.1001/jamainternmed.2020.0994	PROPN
ajlm-1298	60	2	silberstein	silberstein	PROPN
ajlm-1298	60	3	m.	m.	NOUN
ajlm-1298	60	4	correlation	correlation	NOUN
ajlm-1298	60	5	between	between	ADP
ajlm-1298	60	6	premorbid	premorbid	PROPN
ajlm-1298	60	7	il-6	il-6	NUM
ajlm-1298	60	8	levels	level	NOUN
ajlm-1298	60	9	and	and	CCONJ
ajlm-1298	60	10	covid-19	covid-19	PROPN
ajlm-1298	60	11	mortality	mortality	NOUN
ajlm-1298	60	12	:	:	PUNCT
ajlm-1298	60	13	potential	potential	ADJ
ajlm-1298	60	14	role	role	NOUN
ajlm-1298	60	15	for	for	ADP
ajlm-1298	60	16	vitamin	vitamin	NOUN
ajlm-1298	60	17	d.	d.	PROPN
ajlm-1298	60	18	int	int	PROPN
ajlm-1298	60	19	immunopharmacol	immunopharmacol	PROPN
ajlm-1298	60	20	.	.	PUNCT
ajlm-1298	60	21	2020	2020	NUM
ajlm-1298	60	22	nov;88:106995	nov;88:106995	NOUN
ajlm-1298	60	23	.	.	PUNCT
ajlm-1298	61	1	https://doi.org/10.1016/j.intimp.2020.106995	https://doi.org/10.1016/j.intimp.2020.106995	PROPN
ajlm-1298	61	2	liu	liu	PROPN
ajlm-1298	61	3	y	y	PROPN
ajlm-1298	61	4	,	,	PUNCT
ajlm-1298	61	5	du	du	PROPN
ajlm-1298	61	6	x	x	PROPN
ajlm-1298	61	7	,	,	PUNCT
ajlm-1298	61	8	chen	chen	PROPN
ajlm-1298	61	9	j	j	PROPN
ajlm-1298	61	10	,	,	PUNCT
ajlm-1298	61	11	et	et	PROPN
ajlm-1298	61	12	al	al	PROPN
ajlm-1298	61	13	.	.	PROPN
ajlm-1298	62	1	neutrophil	neutrophil	PROPN
ajlm-1298	62	2	-	-	PUNCT
ajlm-1298	62	3	to	to	ADP
ajlm-1298	62	4	-	-	PUNCT
ajlm-1298	62	5	lymphocyte	lymphocyte	NOUN
ajlm-1298	62	6	ratio	ratio	NOUN
ajlm-1298	62	7	as	as	ADP
ajlm-1298	62	8	an	an	DET
ajlm-1298	62	9	independent	independent	ADJ
ajlm-1298	62	10	risk	risk	NOUN
ajlm-1298	62	11	factor	factor	NOUN
ajlm-1298	62	12	for	for	ADP
ajlm-1298	62	13	mortality	mortality	NOUN
ajlm-1298	62	14	in	in	ADP
ajlm-1298	62	15	hospitalized	hospitalize	VERB
ajlm-1298	62	16	patients	patient	NOUN
ajlm-1298	62	17	with	with	ADP
ajlm-1298	62	18	covid-19	covid-19	PROPN
ajlm-1298	62	19	.	.	PUNCT
ajlm-1298	63	1	j	j	PROPN
ajlm-1298	63	2	infect	infect	VERB
ajlm-1298	63	3	.	.	PUNCT
ajlm-1298	64	1	2020;81(1):e6	2020;81(1):e6	NUM
ajlm-1298	64	2	–	–	PUNCT
ajlm-1298	64	3	e12	e12	NOUN
ajlm-1298	64	4	.	.	PUNCT
ajlm-1298	65	1	https://doi.org/10.1016/j.jinf.2020.04.002	https://doi.org/10.1016/j.jinf.2020.04.002	AUX
ajlm-1298	65	2	yan	yan	PROPN
ajlm-1298	65	3	l	l	PROPN
ajlm-1298	65	4	,	,	PUNCT
ajlm-1298	65	5	zhang	zhang	PROPN
ajlm-1298	65	6	ht	ht	PROPN
ajlm-1298	65	7	,	,	PUNCT
ajlm-1298	65	8	goncalves	goncalves	PROPN
ajlm-1298	65	9	j	j	PROPN
ajlm-1298	65	10	,	,	PUNCT
ajlm-1298	65	11	et	et	PROPN
ajlm-1298	65	12	al	al	PROPN
ajlm-1298	65	13	.	.	PUNCT
ajlm-1298	66	1	an	an	DET
ajlm-1298	66	2	interpretable	interpretable	ADJ
ajlm-1298	66	3	mortality	mortality	NOUN
ajlm-1298	66	4	prediction	prediction	NOUN
ajlm-1298	66	5	model	model	NOUN
ajlm-1298	66	6	for	for	ADP
ajlm-1298	66	7	covid-19	covid-19	PROPN
ajlm-1298	66	8	patients	patient	NOUN
ajlm-1298	66	9	.	.	PUNCT
ajlm-1298	67	1	nat	nat	PROPN
ajlm-1298	67	2	mach	mach	PROPN
ajlm-1298	67	3	intell	intell	PROPN
ajlm-1298	67	4	.	.	PUNCT
ajlm-1298	68	1	2020;2(5):283–288	2020;2(5):283–288	X
ajlm-1298	68	2	.	.	X
ajlm-1298	68	3	https://doi.org/10.1038/s42256-020-0180-7	https://doi.org/10.1038/s42256-020-0180-7	NUM
ajlm-1298	68	4	guo	guo	PROPN
ajlm-1298	68	5	t	t	PROPN
ajlm-1298	68	6	,	,	PUNCT
ajlm-1298	68	7	fan	fan	PROPN
ajlm-1298	68	8	y	y	PROPN
ajlm-1298	68	9	,	,	PUNCT
ajlm-1298	68	10	chen	chen	PROPN
ajlm-1298	68	11	m	m	PROPN
ajlm-1298	68	12	,	,	PUNCT
ajlm-1298	68	13	et	et	PROPN
ajlm-1298	68	14	al	al	PROPN
ajlm-1298	68	15	.	.	PUNCT
ajlm-1298	69	1	cardiovascular	cardiovascular	ADJ
ajlm-1298	69	2	implications	implication	NOUN
ajlm-1298	69	3	of	of	ADP
ajlm-1298	69	4	fatal	fatal	ADJ
ajlm-1298	69	5	outcomes	outcome	NOUN
ajlm-1298	69	6	of	of	ADP
ajlm-1298	69	7	patients	patient	NOUN
ajlm-1298	69	8	with	with	ADP
ajlm-1298	69	9	coronavirus	coronavirus	NOUN
ajlm-1298	69	10	disease	disease	NOUN
ajlm-1298	69	11	2019	2019	NUM
ajlm-1298	69	12	(	(	PUNCT
ajlm-1298	69	13	covid-19	covid-19	PROPN
ajlm-1298	69	14	)	)	PUNCT
ajlm-1298	69	15	.	.	PUNCT
ajlm-1298	70	1	jama	jama	PROPN
ajlm-1298	70	2	cardiol	cardiol	PROPN
ajlm-1298	70	3	.	.	PUNCT
ajlm-1298	71	1	2020;5(7):811–818	2020;5(7):811–818	NUM
ajlm-1298	71	2	.	.	PUNCT
ajlm-1298	71	3	https://doi.org/10.1001/jamacardio.2020.1017	https://doi.org/10.1001/jamacardio.2020.1017	PROPN